1,25-dihydroxyvitamin D3 ameliorates high glucose-mediated proliferation, migration, and MCP-1 secretion of vascular smooth muscle cells by inhibiting MAPK phosphorylation
Open Access
- 13 September 2022
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (9)
Abstract
Objectives: To explore the impacts of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) on the proliferation, migration, and monocyte chemoattractant protein-1 (MCP-1) secretion of vascular smooth muscle cells (VSMCs) in a high glucose environment and its possible mechanism. Methods: We extracted VSMCs from the thoracic aorta of a male Sprague–Dawley rats before culturing them in a 25-mM glucose-containing medium in the presence or absence of 1,25(OH)2D3 (10−9 –10−7 M). Cell proliferation was determined by bromodeoxyuridine incorporation assays. Subsequently, cell migratory capacity was examined by performing a transwell assay. An enzyme-linked immunosorbent assay was conducted to assess MCP-1 levels. Protein levels of matrix metalloproteinase-9 (MMP-9), mitogen-activated protein kinases (MAPKs), cyclin D1, and phosphorylated MAPKs were determined by immunoblotting. Results: 1,25(OH)2D3 significantly suppressed the proliferation, migration, and MCP-1 secretion of VSMCs mediated by high glucose in a dose-dependent manner, diminished the enhanced protein expression of MMP-9 and cyclin D1, and attenuated MAPK phosphorylation. The p38 inhibitor SB203580 and ERK1/2 inhibitor PD98059 suppressed high glucose-mediated upregulation of MMP-9 and cyclin D1 protein expression and MCP-1 secretion, respectively. Conclusions: 1,25(OH)2D3 ameliorates high glucose-mediated proliferation, migration, and MCP-1 secretion of VSMCs by inhibiting MAPK phosphorylation, implying a potential therapeutic approach using 1,25(OH)2D3 for diabetic macrovascular complications.Keywords
This publication has 34 references indexed in Scilit:
- Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathwayActa Pharmacologica Sinica, 2012
- Oral Administration of an Active Form of Vitamin D 3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic FunctionsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activityThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cellsThrombosis and Haemostasis, 2008
- MCP-1 mediates TGF-β–induced angiogenesis by stimulating vascular smooth muscle cell migrationBlood, 2006
- 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathwayKidney International, 2006
- Age‐related differences in MAP kinase activity in VSMC in response to glucose or TNF‐αJournal of Cellular Physiology, 2003
- Angiotensin II Signaling in Vascular Smooth Muscle Cells Under High Glucose ConditionsHypertension, 1999
- Vascular smooth muscle cells exhibit increased growth in response to elevated glucoseBiochemical and Biophysical Research Communications, 1992
- 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth.Hypertension, 1989